Realised Investments
MEDEUROPA
On 04 March 2024, Telemos announced the sale of MedEuropa Romania to Affidea. The transaction completed on 21 May 2024.
Since Telemos partnered with management to establish the company in 2018, MedEuropa Romania pursued an ambitious greenfield strategy which saw the successful construction and subsequent operation of 5 state-of-the-art medical centres offering advanced cancer care including radiotherapy, chemotherapy and broader oncology services. The group was able to rapidly deploy resources in a significantly undersupplied market, improving patients’ access to best-in-class quality of care delivered by highly skilled medical professionals and supported by the latest innovative equipment. At the time of sale, MedEuropa Romania was in the process of constructing an additional 3 centres and had firmly established itself as the largest radiotherapy provider in the country with capacity to treat ~5,000 patients annually.
Affidea’s investment will continue to support the business in its mission to enhance the quality and continuum of cancer care for oncological patients throughout Romania.
Realised Investments
Sanoptis
On 19 April 2022, Telemos announced the sale of Sanoptis to Groupe Bruxelles Lambert (GBL). The transaction completed on 1 July 2022.
Since Telemos partnered with management to establish the company in 2018, Sanoptis developed into a leading provider of high quality and innovative ophthalmology treatments, offering a differentiated, doctor-centric proposition to physicians. As a result of the successful execution of the buy-and-build strategy in combination with multiple organic initiatives, Sanoptis rapidly grew into a market leader in Germany and Switzerland. At the time of the sale, the company operated over 250 facilities and performed over 1.3 million conservative and 170,000 surgical procedures annually.
GBL’s investment will build on the success of the company to date and support the next phase of growth for Sanoptis across Europe.
